Status:
COMPLETED
Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance Techniques
Lead Sponsor:
University Health Network, Toronto
Conditions:
Cervix Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
In cervix cancer tumor oxygen levels and fluid pressure in the tumor have been shown to be related to patient outcome. Analysis of the way tumors enhance after intravenous contrast injection using MRI...
Detailed Description
MRI is already used routinely in the radiation planning and staging of carcinoma of the cervix. Prognostic factors such as T-stage (local extent), tumor size and lymphadenopathy are routinely obtained...
Eligibility Criteria
Inclusion
- Cervix cancer intended for radiation therapy
Exclusion
- Contraindication to contrast enhanced MRI and CT
- Prior therapy for cervix cancer
- Prior pelvic radiation
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00242034
Last Update
September 3 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret HOspital
Toronto, Ontario, Canada, M5G 2M9